Literature DB >> 11330417

Increased taurine content in esophageal mucosa of children affected by gastroesophageal reflux.

P D'Eufemia1, G Corrado, R Finocchiaro, M Celli, M Cavaliere, P Troiani, J Tote, E Cardi, O Giardini.   

Abstract

We studied the possible involvement of mucosal amino acid metabolism in the pathogenesis of gastroesophageal reflux disease in children. Eighteen children with gastroesophageal reflux disease (8 with reflux esophagitis and 10 without) and 10 children with normal 24-h esophageal pH monitoring as a comparative group underwent esophagogastroduodenoscopy with biopsies. Plasma and esophageal mucosa amino acids were assayed by liquid chromatography. In children affected by gastroesophageal reflux disease we found an increase of mucosal taurine (P < 0.01) and a decrease of serine (P < 0.01). No differences were noted between patients with and without esophagitis. Significant positive correlations (P < 0.001; r = 0.626) were found between mucosal taurine content and reflux index. Plasma amino acid concentrations did not show any significant differences among groups. Our results indicate that biochemical alterations precede the histological findings of inflammation, likely reflecting the adaptive response of the esophageal mucosa to the gastric contents exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330417     DOI: 10.1023/a:1010756518706

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Recurrent abdominal pains: a field survey of 1,000 school children.

Authors:  J APLEY; N NAISH
Journal:  Arch Dis Child       Date:  1958-04       Impact factor: 3.791

2.  The histological classification of duodenitis in fibreoptic biopsy specimens.

Authors:  R Whitehead; M Roca; D D Meikle; J Skinner; S C Truelove
Journal:  Digestion       Date:  1975       Impact factor: 3.216

Review 3.  The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis.

Authors:  G N Tytgat
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

4.  Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.

Authors:  G Corrado; M Cavaliere; G Frandina; P Rea; C Pacchiarotti; P Capocaccia; E Cardi
Journal:  Ital J Gastroenterol       Date:  1996 Oct-Nov

5.  Increased levels of prostaglandins and nitric oxide in esophageal mucosa of children with reflux esophagitis.

Authors:  A Zicari; G Corrado; M Cavaliere; G Frandina; P Rea; G Pontieri; E Cardi; S Cucchiara
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-02       Impact factor: 2.839

6.  PITC derivatives in amino acid analysis.

Authors:  S A Cohen; B A Bidlingmeyer; T L Tarvin
Journal:  Nature       Date:  1986 Apr 24-30       Impact factor: 49.962

7.  NO chi generation by cultured small intestinal epithelial cells.

Authors:  A U Dignass; D K Podolsky; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

8.  Enhancement of macrophage microbicidal activity: supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi.

Authors:  K A Norris; J E Schrimpf; J L Flynn; S M Morris
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  Protective effect of taurine on indomethacin-induced gastric mucosal injury.

Authors:  M Son; H K Kim; W B Kim; J Yang; B K Kim
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

Review 10.  Immunonutrition: the role of taurine.

Authors:  H P Redmond; P P Stapleton; P Neary; D Bouchier-Hayes
Journal:  Nutrition       Date:  1998 Jul-Aug       Impact factor: 4.008

View more
  1 in total

1.  The relationship between the esophageal tissue content of neurotensin and the presence or absence of esophageal inflammation.

Authors:  Roy Dekel; Robert E Carraway; Colleen Green; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.